Phibro Animal Financials

PAHC Stock  USD 21.90  0.09  0.41%   
Phibro Animal Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At present, Phibro Animal's Other Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 290.9 M, whereas Total Assets are forecasted to decline to about 568.4 M. Key indicators impacting Phibro Animal's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income51.9 M61.3 M
Fairly Down
Very volatile
Current Ratio1.942.65
Way Down
Pretty Stable
The essential information of the day-to-day investment outlook for Phibro Animal includes many different criteria found on its balance sheet. An individual investor should monitor Phibro Animal's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Phibro Animal.

Net Income

2.64 Million

  

Phibro Animal Health Earnings Geography

Please note, the presentation of Phibro Animal's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Phibro Animal's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Phibro Animal's management manipulating its earnings.

Phibro Animal Stock Summary

Phibro Animal competes with Pacira BioSciences,, Dr Reddys, Collegium Pharmaceutical, ANI Pharmaceuticals, and Procaps Group. Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Phibro Anl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1860 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS71742Q1067
CUSIP71742Q106
LocationNew Jersey; U.S.A
Business AddressGlenpointe Centre East,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.pahc.com
Phone201 329 7300
CurrencyUSD - US Dollar

Phibro Animal Key Financial Ratios

Phibro Animal Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets841.3M931.7M971.4M982.2M1.1B568.4M
Other Current Liab70.3M67.0M60.4M78.4M90.2M50.1M
Other Liab46.7M28.0M29.0M31.3M36.0M39.1M
Net Debt376.5M396.2M468.7M454.8M523.1M301.8M
Retained Earnings218.0M247.7M260.9M243.9M280.5M294.5M
Accounts Payable68.4M95.6M73.9M85.6M98.4M64.0M
Cash50.2M74.2M41.3M70.6M81.2M85.3M
Other Assets33.4M35.6M28.0M30.8M35.5M27.9M
Long Term Debt382.7M417.9M452.5M458.3M527.0M553.4M
Net Receivables146.9M166.5M163.5M169.5M194.9M119.4M
Inventory216.3M259.2M277.6M265.9M305.8M160.7M
Other Current Assets42.5M49.3M63.4M51.0M58.7M61.6M
Total Liab602.8M669.3M688.9M725.5M834.4M507.4M
Total Current Assets498.9M566.2M585.7M601.0M691.1M362.1M
Short Term Debt19.3M21.1M33.1M37.3M42.8M45.0M
Intangible Assets62.3M63.9M55.0M45.0M51.8M34.7M
Net Tangible Assets64.5M123.6M145.4M174.2M200.4M210.4M
Short Long Term Debt9.4M15M22.3M29.8M26.8M30.7M

Phibro Animal Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(12.5M)(47.0M)(11.2M)2.6M2.4M2.5M
Change In Cash13.9M24.0M(33.0M)29.3M33.7M35.4M
Free Cash Flow19.0M(5.4M)(38.5M)46.4M53.3M56.0M
Depreciation31.9M32.7M34.0M36.2M41.6M23.3M
Other Non Cash Items(7.0M)(4.8M)1.1M23.3M26.7M28.1M
Capital Expenditures29.3M37.0M51.8M41.2M47.4M23.8M
Net Income54.4M49.2M32.6M2.4M2.8M2.6M
End Period Cash Flow50.2M74.2M41.3M70.6M81.2M85.3M
Dividends Paid18.6M19.4M19.4M19.4M17.5M15.8M
Change Receivables28.7M(18.2M)(23.6M)5.3M6.1M6.4M
Net Borrowings60.4M5.4M50M41.2M47.4M49.8M
Change To Netincome8.7M(8.9M)(6.5M)(12.9M)(11.6M)(11.0M)
Investments12M27.4M(23M)(48.2M)(55.4M)(52.7M)

Phibro Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Phibro Animal's current stock value. Our valuation model uses many indicators to compare Phibro Animal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phibro Animal competition to find correlations between indicators driving Phibro Animal's intrinsic value. More Info.
Phibro Animal Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.75  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Phibro Animal Health is roughly  1.33 . At present, Phibro Animal's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phibro Animal's earnings, one of the primary drivers of an investment's value.

Phibro Animal's Earnings Breakdown by Geography

Phibro Animal Health Systematic Risk

Phibro Animal's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Phibro Animal volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Phibro Animal Health correlated with the market. If Beta is less than 0 Phibro Animal generally moves in the opposite direction as compared to the market. If Phibro Animal Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Phibro Animal Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Phibro Animal is generally in the same direction as the market. If Beta > 1 Phibro Animal moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Phibro Animal Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Phibro Animal's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Phibro Animal growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(3.37)

At present, Phibro Animal's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.

Phibro Animal March 23, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Phibro Animal help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Phibro Animal Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Phibro Animal Health based on widely used predictive technical indicators. In general, we focus on analyzing Phibro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Phibro Animal's daily price indicators and compare them against related drivers.

Complementary Tools for Phibro Stock analysis

When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stocks Directory
Find actively traded stocks across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk